Best Stocks to Buy 2026: A Rare Opportunity

With the S&P 500 at a record 7,519, a rare convergence of macro-driven discounts has placed top-performing stocks at decade-low valuations in mid-2026.

Intuitive Surgical trades 29.5% below its estimated fair value while delivering 17% year-over-year procedure growth and durable annuity-like recurring revenue.
Microsoft's forward P/E of 21.55 sits roughly 20% below its 10-year average, marking one of the cheapest decade entry points for the franchise.
LVMH has suffered its worst calendar-year start on record, prompting a Barclays upgrade and a 32.7% implied upside to a revised €600 price target.

Lead

The S&P 500 closed at 7,519.12 on May 27, 2026 — a fresh all-time high — yet a cluster of blue-chip names are simultaneously trading at their steepest discounts in years. Intuitive Surgical (ISRG), Microsoft (MSFT), Broadcom (AVGO), LVMH (LVMHF), and Micron Technology (MU) have each surfaced as compelling stock buying opportunities in 2026, a condition that rarely coincides with a broad index at record levels.

What's Driving the Discounts

Iran-related energy price volatility and global trade-flow uncertainty have pressured select sectors — healthcare technology, luxury goods, and enterprise software — to valuations well below their five-year averages even as the major indices print new highs. This divergence stands as one of the most pronounced in the past decade, echoing historical episodes where concentrated macro fear manufactured undervalued stocks inside an otherwise rising market.

Q1 2026 corporate earnings reinforced the gap between sentiment and fundamentals: most large-cap U.S. companies delivered profit and revenue above consensus estimates for the period, suggesting that the price compression in specific names reflects geopolitical anxiety rather than deteriorating business models. Progress in U.S.-Iran peace negotiations — President Trump characterized talks as "proceeding nicely" in late May — has already provided a partial catalyst, lifting tech and consumer-discretionary names toward the fresh index highs.

Intuitive Surgical: Recurring Revenue at a 30% Discount

Intuitive Surgical (ISRG) has declined roughly 30% from its early 2025 peak and is down 25.3% year-to-date in 2026, trading near $418.55. The company's independently estimated fair value stands at $593.81 — implying a 29.5% margin of safety at current prices.

The operating data is inconsistent with a distressed business. As of Q1 2026, 11,395 da Vinci robotic surgical systems were installed globally, up 12% year-over-year. Procedure volumes rose 17% over the same period. Approximately 75% of revenue flows from instruments, accessories, and services — a recurring-revenue model shielded from single-period capital-budget cycles. Of the 33 analysts covering ISRG, two-thirds carry buy or strong-buy ratings, with a consensus price target of $570, representing more than 30% upside from current levels. The stock has recovered from at least eight comparable drawdowns since its IPO, each time reaching new all-time highs.

Microsoft: A Franchise Business at Decade-Low Valuation

Microsoft (MSFT) entered June 2026 with a trailing P/E near 25x against a 10-year historical average of approximately 31x — a discount of roughly 20%. The forward P/E registers at 21.55, and the stock carries a GF Score of 97 out of 100, classified as modestly undervalued against a fair value estimate of $551.78.

The compression coincides with the deepest penetration of enterprise AI workloads in the company's history. Azure AI revenue has maintained double-digit sequential growth; Copilot integration across the Office 365 suite continues to expand the addressable base; and data-center capital expenditure is already well advanced. Investors who paid a premium for MSFT in prior years are now offered the same franchise at a structurally lower multiple — a condition the market has historically corrected within 12 to 24 months.

Broadcom: AI Custom Silicon at a Growth-Adjusted Discount

Broadcom (AVGO) carries a trailing P/E above 78x, a number that reads expensive in isolation. The more relevant measure for a high-growth semiconductor company is the price-to-earnings-growth ratio: at 0.88x, AVGO trades below the 1.0 threshold that conventionally defines growth-adjusted undervaluation.

Custom AI chips for hyperscaler clients represent Broadcom's fastest-growing revenue segment. Taiwan Semiconductor (TSM), which fabricates the most advanced nodes used in those chips, trades at a comparably attractive PEG and maintains deep foundry partnerships with Apple and Nvidia. Both companies rank among the most frequently cited best stocks to buy in 2026 for their irreplaceable positions in the global AI infrastructure build-out.

LVMH: Record-Low Entry Point in Luxury

LVMH Moët Hennessy Louis Vuitton (LVMHF) recorded its worst calendar-year start in company history in 2026, as Iran-conflict travel disruptions and softer Chinese consumer spending weighed on fashion, leather goods, and hospitality revenues. The selloff has shifted the sector's valuation to what Barclays describes as the best level in a decade.

Barclays upgraded LVMH to overweight on May 11, raising its price target from €570 to €600 — a 32.7% implied return from the last closing price — citing brand-level turnarounds at Tiffany and Christian Dior driven by creative resets. The bank projects 5.4% revenue growth for LVMH by 2029 against a sector baseline of approximately 4%. Among covering analysts, 18 carry buy recommendations and none a sell, with a consensus 12-month price target of €590.08.

Micron: AI Memory at a Single-Digit Forward Multiple

Micron Technology (MU) joined the $1 trillion market capitalization club in late May 2026 as the S&P 500 set its all-time high close — yet its forward earnings multiple of approximately 9.4x remains among the lowest in large-cap semiconductors. Cyclical skepticism in memory markets has kept the valuation compressed even as AI-driven data-center demand accelerates HBM and high-density DRAM procurement at a pace that is beginning to structurally reshape memory pricing dynamics.

Outlook

The simultaneous presence of index all-time highs and sector-specific valuation troughs has produced an identifiable set of best stocks to buy in 2026 — each trading below its historical norm while its underlying business continues to expand. ISRG, MSFT, AVGO, LVMHF, and MU offer distinct exposure across medical robotics, enterprise software, AI silicon, luxury consumer goods, and semiconductor memory while sharing one common characteristic: prices that have not kept pace with operating performance. Whether geopolitical risk normalizes or corporate earnings continue to outperform expectations, mid-2026 represents a rare stock buying opportunity that long-term investors encounter infrequently when a broad market is trading at record levels.

Mentioned tickers: ISRG, MSFT, AVGO, TSM, LVMHF, MU